Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

NCT03755804 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

232

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma

Interventions

DRUG: bendamustine
DRUG: Etoposide
DRUG: Doxorubicin
DRUG: Bleomycin
DRUG: Vincristine
DRUG: Vinblastine
DRUG: Prednisone
DRUG: Filgrastim
DRUG: Brentuximab Vedotin
DRUG: Cyclophosphamide
DRUG: DTIC
OTHER: Quality of Life Measurements
RADIATION: Radiotherapy

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]
[object Object]